Shares of AngioDynamics ( ANGO -4.24%) were crashing 17.1% lower as of 10:43 a.m. ET on Thursday. The steep sell-off came ...

AngioDynamics, Inc. ANGO reported an adjusted loss per share of 11 cents for first-quarter fiscal 2025, against the year-ago ...

AngioDynamics, Inc. ANGO is well-poised for growth in the coming quarters, courtesy of its potential in NanoKnife System. The ...

Throughout the last three months, 4 analysts have evaluated AngioDynamics ANGO -7.14% Get Free Report , offering a diverse ...

H.C. Wainwright analyst Yi Chen reiterated a Buy rating on AngioDynamics (ANGO – Research Report) today and set a price target of $14.00.

For the year, the company backed its outlook for sales of between $282 million and $288 million and an adjusted loss between 42 cents a share and 38 cents a share. Analysts surveyed by FactSet are ...

For the full year, AngioDynamics expects net sales to be in the range of $282 to $288 million, and adjusted loss per share of between $0.38 and $0.42. Analysts expect the company to report a loss of ...

John Young; Analyst; Canaccord Genuity Yi Chen; Analyst; H.C. Wainwright & Co., LLC ...

AngioDynamics swung to a loss in its fiscal first quarter, although better than feared, and said it continues to expect sales growth in fiscal 2025.

AngioDynamics expects full-year earnings in the range of 38 cents to 42 cents per share, with revenue in the range of $282 million to $288 million. AngioDynamics shares have decreased slightly more ...

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q1 2025 earnings on Oct 3, 2024.The consensus estimate for Q1 2025 revenue is $67.93 million, and the earnings are expected to come in at -$0. ...

Q1 2025 Earnings Conference Call October 3, 2024 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief ...